Q BioMed Inc. - PE Ratio
QBIO
Price:
$0.000099999997
Market Cap:
$14.51K
Q BioMed Inc. functions as a biomedical accelerator and developer, actively licensing, acquiring, and supplying resources to firms within the life sciences and healthcare sectors. Its commercial portfolio includes Metastron (Strontium Chloride SR89), a radiopharmaceutical designed to alleviate pain associated with metastatic bone cancer. Additionally, Q BioMed is advancing a pipeline of therapeutic candidates, including Man-01, a pre-clinical compound aimed at primary open-angle glaucoma; QBM-001, intended for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, which targets liver cancer. The company also collaborates with Mannin Research Inc. on the development of treatment...[Read more]
Industry
Biotechnology
IPO Date
2015-06-17
Stock Exchange
OTC
Ticker
QBIO
PE Ratio
[-0.00]
ROE
[44.12%]
Current Ratio
[0.01]
Dividend Yield
[0%]
Enterprise Value
[4.07M]
Dividend History
The PE Ratio as of July 2026 (TTM) for Q BioMed Inc. (QBIO) is -0.00
According to Q BioMed Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -98.33% compared to the average of -0.30 of the last 4 quarters.
Q BioMed Inc. (QBIO) Historical PE Ratio (quarterly & annually)
How has QBIO PE Ratio performed in the past?
The mean historical PE Ratio of Q BioMed Inc. over the last ten years is -615.12. The current -0.00 PE Ratio has changed -99.92% with respect to the historical average. Over the past ten years (40 quarters), QBIO's PE Ratio was at its highest in in the November 2022 quarter at 0.08. The PE Ratio was at its lowest in in the May 2015 quarter at -375.15.
Average
-615.12
Median
-3.07
Minimum
-6002.40
Maximum
-0.20
Q BioMed Inc. (QBIO) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Q BioMed Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.20
Minimum Annual Increase = -98.28%
Minimum Annual PE Ratio = -6002.40
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.20 | -85.05% |
| 2021 | -1.37 | -19.03% |
| 2020 | -1.69 | -17.50% |
| 2019 | -2.05 | -29.52% |
| 2018 | -2.91 | -9.90% |
| 2017 | -3.23 | -23.72% |
| 2016 | -4.23 | -85.69% |
| 2015 | -29.58 | -71.41% |
| 2014 | -103.49 | -98.28% |
Q BioMed Inc. (QBIO) Average PE Ratio
How has QBIO PE Ratio performed in the past?
The current PE Ratio of Q BioMed Inc. (QBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.09
5-year avg
-1.65
10-year avg
-615.12
Q BioMed Inc. (QBIO) PE Ratio vs. Peers
How is QBIO’s PE Ratio compared to its peers?
Q BioMed Inc.’s PE Ratio is greater than Regenicin, Inc. (-0.02), less than VioQuest Pharmaceuticals, Inc. (-0.00), greater than Strategic Partners A/S (-35.19), less than NovAccess Global Inc. (-0.00), greater than NanoLogix, Inc. (-0.01), less than PaxMedica, Inc. Common Stock (-0.00), greater than Vaxxinity, Inc. (-0.40), less than Scopus BioPharma Inc. (-0.00), less than RenovaCare, Inc. (-0.00), less than Poniard Pharmaceuticals, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.02 | $15.35K | |
| -0.00 | $14.72K | |
| -35.19 | $3.72M | |
| -0.00 | $6.17K | |
| -0.01 | $9.57K | |
| -0.00 | $63.13K | |
| -0.40 | $25.36K | |
| -0.00 | $21.04K | |
| -0.00 | $8.73K | |
| -0.00 | $150.00 |
Build a custom stock screener for Q BioMed Inc. (QBIO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Q BioMed Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Q BioMed Inc. (QBIO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Q BioMed Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Q BioMed Inc.'s PE Ratio?
How is the PE Ratio calculated for Q BioMed Inc. (QBIO)?
What is the highest PE Ratio for Q BioMed Inc. (QBIO)?
What is the 3-year average PE Ratio for Q BioMed Inc. (QBIO)?
What is the 5-year average PE Ratio for Q BioMed Inc. (QBIO)?
How does the current PE Ratio for Q BioMed Inc. (QBIO) compare to its historical average?